Free shipping Orders $49+

Restore MoreIt starts in your gut. It doesn't stop there.

Targeted microbiome formulas for breathing, digestion, metabolism, movement & hormonal balance.

Women's World Magazine
OK! Magazine USA

What More Life Looks Like Day to Day

Subscribe & SaveMake it part of your daily routine. Choose your restoration &test your progress

Your microbiome responds to what you do daily, not occasionally.

Subscribe & Save up to 20%
  • Save up to 20% on every order
  • Skip, cancel or reschedule
  • Never out of stock
  • First access to new formulas

Study References

FDA disclaimer
  1. FDA disclaimer

    Footnote *: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Human Clinical Studies(2)
  1. resB Human Trial

    Footnote 2: Results observed in a 12-week randomized, double-blind, placebo-controlled human clinical study of resB® Lung Support Probiotic. Individual results may vary.

  2. resM Human Trial

    Footnote 3: Based on an 8-week randomized, double-blind, placebo-controlled clinical trial of resM® in 80 adults with BMI 25 to 40 taking 1 capsule daily. Individual results may vary. resM® is not a GLP-1 receptor agonist drug and contains no synthetic GLP-1.

Consumer Studies(1)
  1. resM + resG Combination Study

    Footnote 4: Based on a 60-day prospective, single-arm, open-label consumer study of 20 participants taking resM® and resG prebeet® daily. No control group. Individual results may vary.

Ingredient Studies(1)
  1. resG ingredient Study

    Footnote 6: Results observed after 4 weeks in a randomized, double-blind, placebo-controlled human clinical study of 3.5 g/day Solnul™ resistant potato starch. Individual results may vary. resG® is not a GLP-1 receptor agonist drug and contains no synthetic GLP-1.

Preclinical Lab Studies(4)
  1. resM Lab Study

    Footnote 5: Results observed in preclinical human cellular studies of the finished resM® formula. resM® contains no synthetic GLP-1 and is not a GLP-1 receptor agonist drug.

  2. resG Lab Study

    Footnote 7: Results observed in preclinical human cellular studies of the finished resG® prebeet® formula. resG® contains no synthetic GLP-1 and is not a GLP-1 receptor agonist drug.

  3. resW Lab Study

    Footnote 8: Estrogen-related signaling and B-GUS activity observed in preclinical human cellular studies. resW® contains no synthetic hormones and is not hormone replacement therapy.

  4. resO Lab Study

    Footnote 9: CTX and inflammatory-marker findings observed in preclinical, human cellular studies of resO® Bone & Joint Support Postbiotic.

Pilot Studies(1)
  1. resB Pilot Study

    Footnote 1: Results observed in a human pilot study of resB® Lung Support Probiotic. Individual results may vary.